Literature DB >> 25074469

Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.

Maria Inês Amaro1, Lidia Tajber, Owen I Corrigan, Anne Marie Healy.   

Abstract

PURPOSE: To formulate and investigate the physicochemical properties, physical stability and aerosolization characteristics of nanoporous/nanoparticulate microparticles (NPMPs) prepared by co-spray drying the sugars raffinose pentahydrate (R) or trehalose dihydrate (T) with the cyclic oligosaccharide hydroxypropyl-β-cyclodextrin (HPβCD).
METHODS: Production of powders was carried out using a laboratory scale spray dryer. The resulting powders were characterised by X-ray powder diffraction (XRPD), scanning electron microscopy (SEM), laser diffraction particle sizing, specific surface area analysis (SSA), Fourier transform infrared (FTIR), differential scanning calorimetry (DSC), dynamic vapour sorption (DVS) and aerodynamic assessment using a Next Generation Impactor (NGI).
RESULTS: Powders were amorphous and composed of spherical, porous microparticles with reduced particle size and high specific surface area (~100 m(2)/g). DSC scans showed a single glass transition temperature. FTIR was indicative of the existence of molecular interactions between the carbohydrates. DVS analysis showed an increase in the critical relative humidity (RH) of raffinose and trehalose and eventual crystallization inhibition with increasing concentration of HPβCD. The in vitro deposition showed powders formulated with HPβCD had higher recovered emitted dose and fine particle fraction (<5 μm) than raffinose and trehalose spray dried alone.
CONCLUSIONS: The co-spray drying of raffinose or trehalose with HPβCD results in powders with improved physicochemical characteristics, physical stability and aerodynamic behaviour compared to spray-dried raffinose/trehalose particles, constituting improved potential drug-carrier systems for pulmonary delivery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25074469     DOI: 10.1007/s11095-014-1454-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  43 in total

Review 1.  Amorphous pharmaceutical solids: preparation, characterization and stabilization.

Authors:  L Yu
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

2.  Comparison of particle sizing techniques in the case of inhalation dry powders.

Authors:  C Bosquillon; C Lombry; V Preat; R Vanbever
Journal:  J Pharm Sci       Date:  2001-12       Impact factor: 3.534

3.  Crystallization inhibition of an amorphous sucrose system using raffinose.

Authors:  K M Leinen; T P Labuza
Journal:  J Zhejiang Univ Sci B       Date:  2006-02       Impact factor: 3.066

4.  The effect of dehydration conditions on the functionality of anhydrous amorphous raffinose.

Authors:  Sai Prasanth Chamarthy; Nawel Khalef; Niraj Trasi; Aziz Bakri; M Teresa Carvajal; Rodolfo Pinal
Journal:  Eur J Pharm Sci       Date:  2010-03-16       Impact factor: 4.384

5.  Alternative oral exemestane formulation: improved dissolution and permeation.

Authors:  Burçin Yavuz; Erem Bilensoy; Imran Vural; Murat Sumnu
Journal:  Int J Pharm       Date:  2010-08-03       Impact factor: 5.875

6.  A Fourier transform infrared microspectroscopy study of sugar glasses: application to anhydrobiotic higher plant cells.

Authors:  W F Wolkers; H Oldenhof; M Alberda; F A Hoekstra
Journal:  Biochim Biophys Acta       Date:  1998-01-08

Review 7.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

8.  The glass transition temperature of mixtures of trehalose and hydroxyethyl starch.

Authors:  Tani Chen; Sankha Bhowmick; Andreas Sputtek; Alex Fowler; Mehmet Toner
Journal:  Cryobiology       Date:  2002-06       Impact factor: 2.487

9.  Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.

Authors:  Z Shao; R Krishnamoorthy; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

10.  Crystal structure of an anhydrous form of trehalose: structure of water channels of trehalose polymorphism.

Authors:  H Nagase; N Ogawa; T Endo; M Shiro; H Ueda; M Sakurai
Journal:  J Phys Chem B       Date:  2008-07-08       Impact factor: 2.991

View more
  4 in total

1.  A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.

Authors:  S Focaroli; P T Mah; J E Hastedt; I Gitlin; S Oscarson; J V Fahy; A M Healy
Journal:  Int J Pharm       Date:  2019-03-05       Impact factor: 5.875

2.  Immediate Release Formulation of Inhaled Beclomethasone Dipropionate-Hydroxypropyl-Beta-Cyclodextrin Composite Particles Produced Using Supercritical Assisted Atomization.

Authors:  Hsien-Tsung Wu; Yao-Hsiang Chuang; Han-Cyuan Lin; Tzu-Chieh Hu; Yi-Jia Tu; Liang-Jung Chien
Journal:  Polymers (Basel)       Date:  2022-05-23       Impact factor: 4.967

Review 3.  Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2018-01-14

4.  Moisture-Resistant Co-Spray-Dried Netilmicin with l-Leucine as Dry Powder Inhalation for the Treatment of Respiratory Infections.

Authors:  Yingtong Cui; Xuejuan Zhang; Wen Wang; Zhengwei Huang; Ziyu Zhao; Guanlin Wang; Shihao Cai; Hui Jing; Ying Huang; Xin Pan; Chuanbin Wu
Journal:  Pharmaceutics       Date:  2018-12-01       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.